Bedside catheter hematoma evacuation with consecutive urokinase-lysis in supratentorial intracerebral hemorrhage: feasibility, safety and efficacy

Recruiting

• Conditions: I61.9; Intracerebral haemorrhage, unspecified

• Registration Number: DRKS00007908
• Lead Sponsor: eurologisches Universitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Treatment of all patients with supratentorial intracerebral hemorrhage >25ml with minimally-invasive technique with catheter. Reason of intracerebral hemorrhage can be one of the following: oral anticoagulation, hypertonus, amyloid angiopathy, systemic thrombolysis-assoziated hemorrhage

Exclusion Criteria

withdrawal of therapy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evolution of hematoma volume, edema volume and midline shift in brain imaging(CT/MRT) during therapy up to day 7

Secondary Outcome Measures

Name	Time	Method
In-hospital mortality, National Institutes of Health Stroke Scale at discharge, modified Rankin Scale at discharge,<br>safety (re-bleeding, local infections, location of catheter, need for correction of catheter)